Publications by authors named "Edwin Aird"

Claim this Profile
T
Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer.
Ian H Kunkler, Nicola S Russell, Niall Anderson, Richard Sainsbury, J Michael Dixon, Edwin Aird

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials.
Catharine H Clark, Edwin G A Aird, Steve Bolton, Elizabeth A Miles, Andrew Nisbet

Br J Radiol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre 'end to end' dosimetry audit for cervix HDR brachytherapy treatment.
Antony L Palmer, Patricia Diez, Laura Gandon, Andrea Wynn-Jones, Peter Bownes, Edwin Aird

Radiother Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global harmonization of quality assurance naming conventions in radiation therapy clinical trials.
Christos Melidis, Walther R Bosch, Joanna Izewska, Elena Fidarova, Eduardo Zubizarreta, Edwin Aird

Int J Radiat Oncol Biol Phys· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation therapy quality assurance in clinical trials--Global Harmonisation Group.
Christos Melidis, Walter R Bosch, Joanna Izewska, Elena Fidarova, Eduardo Zubizarreta, Edwin G A Aird

Radiother Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.
David P Dearnaley, Gordana Jovic, Isabel Syndikus, Vincent Khoo, Richard A Cowan, Edwin G Aird

Lancet Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution to normal tissue dose from concomitant radiation for two common kV-CBCT systems and one MVCT system used in radiotherapy.
Andrew Shah, Edwin Aird, Jane Shekhdar

Radiother Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility.
Alysa Fairchild, Edwin Aird, Paul A Fenton, Vincent Gregoire, Akos Gulyban

Radiother Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting.
Damien C Weber, Philip M P Poortmans, Coen W Hurkmans, Edwin Aird, Akos Gulyban

Radiother Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation dose from volumetric helical perfusion CT of the thorax, abdomen or pelvis.
Vicky Goh, Minaxi Dattani, Joseph Farwell, Jane Shekhdar, Emily Tam, Edwin Aird

Eur Radiol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning.
Elena Musat, Erik Roelofs, Raquel Bar-Deroma, Paul Fenton, Akos Gulyban, Edwin Aird

Radiother Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397.
Sarah L Gulliford, Kerwyn Foo, Rachel C Morgan, Edwin G Aird, A Margaret Bidmead

Int J Radiat Oncol Biol Phys· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetry and field matching for radiotherapy to the breast and supraclavicular fossa.
Elizabeth A Miles, Karen Venables, Peter J Hoskin, Edwin G A Aird,

Radiother Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century.
Tom Budiharto, Elena Musat, Philip Poortmans, Coen Hurkmans, Angelo Monti, Edwin Aird

Radiother Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance of dosimetry and the impact on sample size in randomized clinical trials.
Morten N Pettersen, Edwin Aird, Dag R Olsen

Radiother Oncol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial.
David P Dearnaley, Matthew R Sydes, John D Graham, Edwin G Aird, David Bottomley

Lancet Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A versatile phantom for quality assurance in the UK Medical Research Council (MRC) RT01 trial (ISRCTN47772397) in conformal radiotherapy for prostate cancer.
A Rollo Moore, A P Jim Warrington, Edwin G A Aird, A Margaret Bidmead, David P Dearnaley

Radiother Oncol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two dimensional and three dimensional radiotherapy treatment planning in locally advanced non-small cell lung cancer treated with continuous hyperfractionated accelerated radiotherapy weekend less.
Elena M Wilson, Frances Joy Williams, Basil Ethan Lyn, Edwin G A Aird

Radiother Oncol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397).
W Philip M Mayles, A Rollo Moore, Edwin G A Aird, A Margaret Bidmead, David P Dearnaley

Radiother Oncol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.
Matthew R Sydes, Richard J Stephens, A Rollo Moore, Edwin G Aird, A Margaret Bidmead

Radiother Oncol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial.
Karen Venables, Elizabeth A Miles, Edwin G A Aird, Peter J Hoskin,

Radiother Oncol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of active breathing control in patients with non-small-cell lung cancer to be treated with CHARTWEL.
Elena M Wilson, F Joy Williams, B Ethan Lyn, John W Wong, Edwin G A Aird

Int J Radiat Oncol Biol Phys· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional distribution of radiation within the breast: an intercomparison of departments participating in the START trial of breast radiotherapy fractionation.
Karen Venables, Elizabeth A Winfield, Edwin G A Aird, Peter J Hoskin

Int J Radiat Oncol Biol Phys· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis